Slowing progression of Alzheimer’s disease by modulating the kynurenine pathway [ 2017 - 2019 ]

Research Grant

[Cite as]

Researchers: Prof Gilles Guillemin (Principal investigator) ,  Dr Nady Braidy Dr David Lovejoy

Brief description Chronic inflammation in the brain in known to be a factor in the progression of Alzheimer's disease. We are exploring if blocking a particular enzyme in a biochemical pathway involved in inflammation, can improve symptoms, or slow progression, of the disease in animal models of AD. If results are as expected, our proposal has the potential to generate a new a therapy for AD.

Funding Amount $AUD 592,522.11

Funding Scheme Project Grants

Notes Standard Project Grant

Click to explore relationships graph
Viewed: [[ro.stat.viewed]]